Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-05
DOI
10.1002/cam4.3078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy
- (2019) Sajad Yaghoubi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
- (2018) S Banerjee et al. ANNALS OF ONCOLOGY
- Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
- (2018) Raffaella Rossin et al. Nature Communications
- Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
- (2018) Meghdad Abdollahpour-Alitappeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity
- (2017) Jillian M. Prendergast et al. mAbs
- Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with 89Zr-5B1
- (2017) Jacob L. Houghton et al. MOLECULAR PHARMACEUTICS
- A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy
- (2016) Andre Goy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates
- (2015) Remon van Geel et al. BIOCONJUGATE CHEMISTRY
- Diabody Pretargeting with Click Chemistry In Vivo
- (2015) S. M. J. van Duijnhoven et al. JOURNAL OF NUCLEAR MEDICINE
- In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
- (2015) Penny Bryant et al. MOLECULAR PHARMACEUTICS
- Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine Ligation
- (2013) Ron M. Versteegen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Site-Specific Conjugation of Monodispersed DOTA-PEGn to a Thiolated Diabody Reveals the Effect of Increasing PEG Size on Kidney Clearance and Tumor Uptake with Improved 64-Copper PET Imaging
- (2011) Lin Li et al. BIOCONJUGATE CHEMISTRY
- In Vivo Imaging of Transplanted Islets with64Cu-DO3A-VS-Cys40-Exendin-4 by Targeting GLP-1 Receptor
- (2011) Zhanhong Wu et al. BIOCONJUGATE CHEMISTRY
- Tunable Degradation of Maleimide–Thiol Adducts in Reducing Environments
- (2011) Aaron D. Baldwin et al. BIOCONJUGATE CHEMISTRY
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives
- (2009) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Surgical Management of Recurrent Ovarian Cancer
- (2009) Mario M. Leitao et al. SEMINARS IN ONCOLOGY
- A new TAG-72 cancer marker peptide identified by phage display
- (2008) Ling Chen et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now